3D Cell Culture Market By Application (Cancer Cell Research, Cell Based Assays/Toxicity Screening, Regenerative Medicine/Tissue Engineering, In Vivo Applications For Stem Cells, 3D Printing/Microfluidics), By Technology (Scaffold Based, Scaffold Free), By End User (Biotechnology And Pharmaceutical Industries, Research Laboratories, Hospitals And Diagnostic Centers), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 19, 2016

Key Findings


The global 3D cell culture market has been expected to grow at the CAGR of 24.7% during 2016-2022. Growing prevalence rate of cancer is the major driver of 3D cell culture market. 3D cell culture has been anticipated to witness commercialization over the forecasted period due to various factors that are positively boosting the market such as adoption of green initiatives, improving energy efficiency, supportive government legislation and so on. 3D cell culture is artificially or manmade created environment. The market is majorly driven by the increasing cases of cancer. Across the world,increasing cancer cases is one of the major cause of concern. As per the American society the new cases of cancer and deaths by cancer is due to the existing cancer burden.Lack of experienced professionals, high price in cell biology research and lack of organizations are the major restraints in the 3D cell culture market. Focused research and development investments and demand for organ transplant has been increasing, seems to be opportunistic factor to this market.


Market Segment Insight


The global market of 3D cell culture is segmented on the basis of application, technology, end userand regional outlook. Basedon application, the market has been categorized intocancer cell research, cell based assays/toxicity screening, regenerative medicines/ tissue engineering, vivo applications for stem cells, printing micro fluidics and others. Regenerative medicines/ tissue engineering dominates the application sector of 3D cell culture market. As per the cancer cell research, application segment dominated the market in 2015 because of the increasing investment in tumor cells 3D environment. The 3D cell culture market is further segregated on the basis of technology including scaffold based and scaffold free. Scaffold based is divide in hydrogels/ECM analogs, solid scaffolds and micropatterened surfaces, scaffold free is segmented in hanging drop plates, 3-D bioreactors, magnetic levitations & 3D bio printing, microfluidics, ultra-low attachment plates, and 3-D petrisidhes. Scaffold based segment dominated the market in 2015. And by the end user, 3D cell market is divided in four parts such as – biotechnology and pharmaceutical industries, research laboratories, hospitals and diagnostic centers and others. In the end user segment, the biotechnology and pharmaceutical industries are leading the market of 3D cell culture market as they are growing their research programs in this area.


Regional Insight


On the basis of regional outlook 3D cell culture market is divided in North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. In 2015, North America dominated with the largest share in the global 3D cell culture and it has been expected that in the coming year it will continue to lead themarket followed by Europe, Asia Pacific and Rest of the world. The growth in this regions is rising due to increase in the number of researchin 3D cell culture market mainly in Japan, increasing government initiatives and increasing per capita incomes and so on.Major share of the North America in 3D cell culture market has been rising support by the government in the form of donations and funding, rising cancer cases, increasing biopharmaceutical industries, launching of new products and many more.


Competitive Insights


Some of the key players of the industries are-3D Biotek LLC., Bell Brook Labs., Corning Incorporated, Corning Life Sciences, D Biomatrix Inc., Global Cell Solutions, Hi Media Laboratories, Insphero AG, Kurray Co.Ltd, Lonza AG, Nanofiber Solutions, Promocell GmbH, Reinnervate Ltd.Acquisitions, innovations, and mergers are the key strategies adopted by the players so as to increase the share of their company. On 14th August 2014 Reinnevate Ltd., one of the top leading company in the field of 3D cell culture market has been acquired by Reprocell of Shin-Yokohama in Japan.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL 3D CELL CULTURE MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL 3D CELL CULTURE MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL 3D CELL CULTURE MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL 3D CELL CULTURE MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.3. KEY OPPORTUNITIES 14
3.4. CHALLENGES 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL 3D CELL CULTURE MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL 3D CELL CULTURE MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL 3D CELL CULTURE MARKET- GAP ANALYSIS 15


CHAP 5. GLOBAL 3D CELL CULTURE MARKET BY APPLICATION 2012-2022 ($ MILLION) 16
5.1. GLOBAL CANCER CELL RESEARCH MARKET 2012-2022 ($ MILLION) 16
5.2. GLOBAL CELL BASED ASSAYS/TOXICITY SCREENING MARKET 2012-2022 ($ MILLION) 16
5.3. GLOBAL REGENERATIVE MEDICINE/TISSUE ENGINEERING MARKET 2012-2022 ($ MILLION) 16
5.4. GLOBAL IN VIVO APPLICATIONS FOR STEM CELLS MARKET 2012-2022 ($ MILLION) 16
5.5. GLOBAL 3D PRINTING/MICROFLUIDICS MARKET 2012-2022 ($ MILLION) 16
5.6. GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 16


CHAP 6. GLOBAL 3D CELL CULTURE MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 17
6.1. GLOBAL SCAFFOLD BASED MARKET 2012-2022($ MILLION) 17
6.2. GLOBAL SCAFFOLD FREE MARKET 2012-2022($ MILLION) 17


CHAP 7. GLOBAL 3D CELL CULTURE MARKET BY END USER 2012-2022 ($ MILLION) 18
7.1. GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES MARKET 2012-2022 ($ MILLION) 18
7.2. GLOBAL RESEARCH LABORATORIES MARKET 2012-2022 ($ MILLION) 18
7.3. GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS MARKET 2012-2022 ($ MILLION) 18
7.4. GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 18


CHAP 8. GLOBAL 3D CELL CULTURE MARKET, REGIONAL OUTLOOK 2012-2022 ($ MILLION) 19
8.1. NORTH AMERICA 19
8.1.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.1.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.1.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
8.1.3.1. U.S. 19
8.1.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.1.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.1.3.2. CANADA 19
8.1.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.1.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.2. EUROPE 19
8.2.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.2.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.2.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
8.2.3.1. GERMANY 19
8.2.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.2.3.2. UK 20
8.2.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.2.3.3. FRANCE 20
8.2.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.2.3.4. SPAIN 20
8.2.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.2.3.5. REST OF EUROPE 20
8.2.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 20
8.2.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 20
8.3. ASIA PACIFIC 20
8.3.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.3.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
8.3.3.1. CHINA 20
8.3.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.2. INDIA 21
8.3.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.3. JAPAN 21
8.3.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
8.3.3.4. OTHERS 21
8.3.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 21
8.3.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 21
8.4. MIDDLE EAST & AFRICA 21
8.4.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.4.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.5. LATIN AMERICA 21
8.5.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.5.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.5.2.1. BRAZIL 21
8.5.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.5.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22


CHAP 9. COMPETITIVE LANDSCAPE 23
9.1. 3D BIOTEK LLC. 24
9.1.1. COMPANY OVERVIEW 24
9.1.2. FINANCIAL PERFORMANCE 24
9.1.3. PRODUCT BENCHMARKING 24
9.1.4. STRATEGIC INITIATIVES 24
9.2. BELL BROOK LABS. 24
9.2.1. COMPANY OVERVIEW 24
9.2.2. FINANCIAL PERFORMANCE 24
9.2.3. PRODUCT BENCHMARKING 24
9.2.4. STRATEGIC INITIATIVES 24
9.3. CORNING INCORPORATED 24
9.3.1. COMPANY OVERVIEW 24
9.3.2. FINANCIAL PERFORMANCE 24
9.3.3. PRODUCT BENCHMARKING 24
9.3.4. STRATEGIC INITIATIVES 24
9.4. CORNING LIFE SCIENCES 24
9.4.1. COMPANY OVERVIEW 24
9.4.2. FINANCIAL PERFORMANCE 24
9.4.3. PRODUCT BENCHMARKING 24
9.4.4. STRATEGIC INITIATIVES 24
9.5. D BIOMATRIX INC. 24
9.5.1. COMPANY OVERVIEW 24
9.5.2. FINANCIAL PERFORMANCE 24
9.5.3. PRODUCT BENCHMARKING 24
9.5.4. STRATEGIC INITIATIVES 24
9.6. GLOBAL CELL SOLUTIONS 24
9.6.1. COMPANY OVERVIEW 24
9.6.2. FINANCIAL PERFORMANCE 25
9.6.3. PRODUCT BENCHMARKING 25
9.6.4. STRATEGIC INITIATIVES 25
9.7. HI MEDIA LABORATORIES 25
9.7.1. COMPANY OVERVIEW 25
9.7.2. FINANCIAL PERFORMANCE 25
9.7.3. PRODUCT BENCHMARKING 25
9.7.4. STRATEGIC INITIATIVES 25
9.8. INSPHERO AG 25
9.8.1. COMPANY OVERVIEW 25
9.8.2. FINANCIAL PERFORMANCE 25
9.8.3. PRODUCT BENCHMARKING 25
9.8.4. STRATEGIC INITIATIVES 25
9.9. KURRAY CO.LTD 25
9.9.1. COMPANY OVERVIEW 25
9.9.2. FINANCIAL PERFORMANCE 25
9.9.3. PRODUCT BENCHMARKING 25
9.9.4. STRATEGIC INITIATIVES 25
9.10. LONZA AG 25
9.10.1. COMPANY OVERVIEW 25
9.10.2. FINANCIAL PERFORMANCE 25
9.10.3. PRODUCT BENCHMARKING 25
9.10.4. STRATEGIC INITIATIVES 25
9.11. NANOFIBER SOLUTIONS 25
9.11.1. COMPANY OVERVIEW 25
9.11.2. FINANCIAL PERFORMANCE 25
9.11.3. PRODUCT BENCHMARKING 25
9.11.4. STRATEGIC INITIATIVES 25
9.12. PROMOCELL GMBH 26
9.12.1. COMPANY OVERVIEW 26
9.12.2. FINANCIAL PERFORMANCE 26
9.12.3. PRODUCT BENCHMARKING 26
9.12.4. STRATEGIC INITIATIVES 26
9.13. REINNERVATE LTD. 26
9.13.1. COMPANY OVERVIEW 26
9.13.2. FINANCIAL PERFORMANCE 26
9.13.3. PRODUCT BENCHMARKING 26
9.13.4. STRATEGIC INITIATIVES 26
9.14. SIGMA-ALDRICH CO.LLC. 26
9.14.1. COMPANY OVERVIEW 26
9.14.2. FINANCIAL PERFORMANCE 26
9.14.3. PRODUCT BENCHMARKING 26
9.14.4. STRATEGIC INITIATIVES 26
9.15. THERMO FISHER SCIENTIFIC 26
9.15.1. COMPANY OVERVIEW 26
9.15.2. FINANCIAL PERFORMANCE 26
9.15.3. PRODUCT BENCHMARKING 26
9.15.4. STRATEGIC INITIATIVES 26

TABLE 1 GLOBAL 3D CELL CULTURE MARKET BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 2 GLOBAL CANCER CELL RESEARCH MARKET 2012-2022 ($ MILLION) 27
TABLE 3 GLOBAL CELL BASED ASSAYS/TOXICITY SCREENING MARKET 2012-2022 ($ MILLION) 27
TABLE 4 GLOBAL REGENERATIVE MEDICINE/TISSUE ENGINEERING MARKET 2012-2022 ($ MILLION) 28
TABLE 5 GLOBAL IN VIVO APPLICATIONS FOR STEM CELLS MARKET 2012-2022 ($ MILLION) 28
TABLE 6 GLOBAL 3D PRINTING/MICROFLUIDICS MARKET 2012-2022 ($ MILLION) 28
TABLE 7 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 28
TABLE 8 GLOBAL 3D CELL CULTURE MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 28
TABLE 9 GLOBAL SCAFFOLD BASED MARKET 2012-2022 ($ MILLION) 28
TABLE 10 GLOBAL HYDROGELS/ECM ANALOGS MARKET 2012- 2022 ($ MILLION) 28
TABLE 11 GLOBAL SOLID SCAFFOLDS MARKET 2012- 2022 ($ MILLION) 28
TABLE 12 GLOBAL MICROPATTERENED SURFACES MARKET 2012- 2022 ($ MILLION) 28
TABLE 13 GLOBAL SCAFFOLD FREE MARKET 2012-2022($ MILLION) 28
TABLE 14 GLOBAL HANGING DROP PLATES MARKET 2012- 2022 ($ MILLION) 28
TABLE 15 GLOBAL 3-D BIOREACTORS MARKET 2012- 2022 ($ MILLION) 28
TABLE 16 GLOBAL MAGNETIC LEVITATIONS & 3D BIOPRINTING MARKET 2012- 2022 ($ MILLION) 28
TABLE 17 GLOBAL MICROFLUIDICS MARKET 2012- 2022 ($ MILLION) 28
TABLE 18 GLOBAL ULTRA-LOW ATTACHMENT PLATES MARKET 2012- 2022 ($ MILLION) 28
TABLE 19 GLOBAL 3-D PETRISIDHES MARKET 2012- 2022 ($ MILLION) 28
TABLE 20 GLOBAL 3D CELL CULTURE MARKET BY END USER 2012-2022 ($ MILLION) 28
TABLE 21 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES MARKET 2012-2022 ($ MILLION) 28
TABLE 22 GLOBAL RESEARCH LABORATORIES MARKET 2012-2022 ($ MILLION) 29
TABLE 23 GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS MARKET 2012-2022 ($ MILLION) 29
TABLE 24 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 29
TABLE 25 GLOBAL 3D CELL CULTURE MARKET BY REGION 2012-2022 ($ MILLION) 29
TABLE 26 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 27 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 28 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 29 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 30 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 31 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 32 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 33 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 34 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 35 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 36 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 37 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 38 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 39 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 40 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 41 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 42 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 43 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 44 RUSSIA MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 30
TABLE 45 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 46 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 47 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 30
TABLE 48 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 49 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 50 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 51 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 52 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 53 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 54 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 55 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 30
TABLE 56 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 57 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 58 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 59 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 60 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 61 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 62 BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31

FIGURE # 1 MARKET SHARE BY REGIONS 31
FIGURE # 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 8 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 9 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE # 10 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE # 11 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE # 12 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE # 13 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE # 14 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE # 15 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE # 16 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)